Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2003

View Archived Issues

Potential new applications reported for the antidepressant milnacipran

Clinical trial assesses combination of NMDA antagonist and morphine in chronic pain

Effective analgesia induced by LAS-34475 in postoperative dental pain

Evidence of efficacy for erlosamide in neuropathic pain

Preclinical results for NeuGene agents against single-stranded RNA viruses

JUPITER assesses effect of Crestor on cardiovascular disease risk reduction

BlockAide/CR appears to target diverse HIV-1 strains

Pyrrolidine CCR5 receptor modulators identified by Merck

New P2Y agonists with utility in COPD therapy presented by Celltech

CV Therapeutics identifies adenosine A3 receptor agonists with utility in cancer and neutropenia

Celltech researchers describe hydroxamate-based MMP inhibitors

New series of analgesic NMDA glycine-site antagonists under study at Gruenenthal

Melacure claims melanocortin receptor modulators for obesity, inflammation, etc.

Roche scientists prepare and test new 5-HT6 receptor ligands

New antiparkinsonian adenosine A2A antagonists discovered at Sigma-Tau

New antibacterial macrolides in early development at Enanta

Photofrin approved in Canada for HGD associated with Barrett's esophagus

European approval for Nutropin AQ

Launch date set for Finacea

Fuzeon 48-week data reported, progressive distribution program planned

Novel analgesic from Otsuka useful for peripheral neuropathic pain

Antihyperalgesic effects determined for UCB-34714 in rat models of neuropathic pain

Hong Kong researchers succeed in isolating virus responsible for SARS

First findings supporting UCB-34714 as an improved antiepileptic agent

Italian investigators identify potent new ARIs with potential in diabetic complications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...